No writing assistance was utilized in the production of this manuscript. Homozygous familial hypercholesterolemia is a rare but significant cause of early-onset coronary heart disease. Early ...

Although evidence of benefit is based mainly on nonrandomized data, the procedure is widely accepted as first-line therapy for homozygous familial hypercholesterolemia and is increasingly used to ...